New Zealand markets close in 5 hours 38 minutes

Clovis Oncology, Inc. (CLVS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.2915-0.0523 (-15.21%)
At close: 04:00PM EST
0.2910 -0.00 (-0.17%)
After hours: 05:15PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
133,020
148,757
164,522
143,006
95,388
Cost of revenue
36,966
38,826
41,305
34,686
22,074
Gross profit
96,054
109,931
123,217
108,320
73,314
Operating expenses
Research development
151,279
186,602
257,707
283,146
231,347
Selling general and administrative
125,528
128,400
163,894
182,769
175,781
Total operating expenses
302,742
330,222
425,405
475,626
407,128
Operating income or loss
-206,688
-220,291
-302,188
-367,306
-333,814
Interest expense
34,908
31,673
23,491
16,547
13,183
Total other income/expenses net
-8,477
-10,534
-37,063
-11,915
-20,404
Income before tax
-252,312
-264,928
-369,759
-398,626
-367,401
Income tax expense
-406
-404
-547
1,798
608
Income from continuing operations
-251,906
-264,524
-369,212
-400,424
-368,009
Net income
-251,906
-264,524
-369,212
-400,424
-368,009
Net income available to common shareholders
-251,906
-264,524
-369,212
-400,424
-368,009
Basic EPS
-
-2.29
-4.38
-7.43
-7.07
Diluted EPS
-
-2.29
-4.38
-7.43
-7.07
Basic average shares
-
115,528
84,307
53,873
52,066
Diluted average shares
-
115,528
84,307
53,873
52,066
EBITDA
-
-224,759
-338,070
-374,311
-349,617